" 201.50 
statement of identity. 
(a) the label of prescription and insulin-containing drugs in package form shall bear as one of its principal features a statement of the identity of the drug. 
(b) such statement of identity shall be in terms of the established name of the drug. in the case of a prescription drug that is a mixture and that has no established name, the requirement for statement of identity shall be deemed to be satisfied by a listing of the quantitative ingredient information as prescribed by  201.10. 
(c) the statement of identity of a prescription drug shall also comply with the placement, size and prominence requirements of  201.10. 

